A detailed history of Johnson Midwest Financial, LLC transactions in Viatris Inc stock. As of the latest transaction made, Johnson Midwest Financial, LLC holds 50 shares of VTRS stock, worth $650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$650
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023

BUY
$9.02 - $10.29 $9 - $10
1 Added 2.04%
50 $0
Q1 2023

Apr 18, 2023

BUY
$9.2 - $12.26 $9 - $12
1 Added 2.08%
49 $0
Q2 2022

Jul 18, 2022

BUY
$9.95 - $12.27 $149 - $184
15 Added 45.45%
48 $0
Q4 2021

Jan 26, 2022

BUY
$12.09 - $14.68 $12 - $14
1 Added 3.13%
33 $0
Q1 2021

Apr 14, 2021

BUY
$13.59 - $18.54 $67 - $92
5 Added 18.52%
32 $0
Q4 2020

Jan 20, 2021

BUY
$14.3 - $18.74 $386 - $505
27 New
27 $1,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Johnson Midwest Financial, LLC Portfolio

Follow Johnson Midwest Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Midwest Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Midwest Financial, LLC with notifications on news.